N 35/2024

(To be published in the Gazette of India Extraordinary Part-II, Section - 3, Sub-Section (ii))

Government of India Ministry of Commerce & Industry Department of Commerce Directorate General of Foreign Trade Vanijya Bhawan, New Delhi Notification No. 35/2024-25 New Delhi,. Dated: | EFOctober 2024

Subject: Amendment in Export Policy condition of Cough Syrup under Chapter 30 of Schedule-II (Export Policy) of ITC (HS) 2022-reg.

In exercise of powers conferred by Section 3 read with section 5 of the Foreign Trade (Development & Regulation) Act, 1992, read with Para 1.02 and 2.01 of the Foreign Trade Policy 2023, as amended from time to time, and in continuation ofthe Notification No. 06/2023 dated 22.05.2023, the Central Government amends the Export Policy condition for HSN 3004 under Chapter 30, Schedule-II (Export Policy) of ITC(HS) 2022, with immediate effect as under:

|Policy|ExistingPolicyCondition|ExistingPolicyCondition|Revised PolicyCondition|Revised PolicyCondition||
|---|---|---|---|---|---|
|ondition||||||
|INo.||||||
||CoughSyrup shall be permitted to(i)<br>beexportedsubject totheexport<br>samplebeingtested and||(i) Cough“Syrup shall‘be permitted to be<br>exported subject to the export sample being<br>ested<br>and<br>production<br>of Certificate<br>of|||
||productionofCertificate of||Analysis(CoA) issuedbyanyofthefollowing|||
||Analysis (CoA) issued by anyof|||laboratories:|||
||he following laboratories:||e|;<br>;<br>Ci<br>Indian Pharmacopoeia Commission,||
||e|Indian Pharmacopoeia||Ghaziabad, UttarPradesh||
|||Commission, Ghaziabad,<br>UttarPradesh|e|CDL, Kolkata,WestBengal||
||©|CDL,Kolkata,West|e|CDTL,Chennai,TamilNadu||
|||Bengal|e|CDTL,Mumbai, Maharashtra||
||¢|CDTL, Chennai,Tamil|e|CDTL, Hyderabad, Telangana||
|||Nadu||||
||||e|RODTL, Chandigarh||
||e|CDTL, Mumbai,||||
|||Maharashtra|e|RDTL, Guwahati,Assam||
||e|CDTL, Hyderabad,|e|Any NABL accredited State|Drugs|
|||Telangana||Testing Laboratory||
||e|RDTL, Chandigarh|*|BeePharmoLabs Pvt. LtdThane,C2<br>Hatkesh<br>Udyog<br>Nagar,<br>Mira||

|¢|RDTL, Guwahati,Assam||- Bhayander Road, Mira Road (East),|
|---|---|---|---|
||||thane-401107, Maharastra.|
|e|AnyNABL accredited|||
||State DrugsTesting||e<br>Oasis Test House, 24-A, B<br>Sardar|
||Laboratory||Patel,<br>industrial<br>Estate,<br>Narol,|
|e|Bee Pharmo Labs Pvt. Ltd||Ahmedabad-382407, Gujarat.|
||Thane, C 2 Hatkesh||e<br>Shriram<br>Institute<br>for<br>Industrial|
||Udyog Nagar, Mira||Research (A unit ofShriram Scientific|
||Bhayander Road, Mira||and Industrial Research Foundation),|
||Road (East), thane-||19-University<br>Road,<br>New<br>Delhi-|
||401107, Maharastra.||110007|
|e|OasisTest House, 24-A, B|||(ii) In case, the manufacturers are exporting|
||Sardar Patel, industrial||the Cough Syrup to USA, UK, Canada, EU,|
||Estate, Narol, Ahmedabad-JJapan,<br>Australia,<br>Singapore,<br>Republic<br>of|||
||382407, Gujarat.||Korea and Switzerland, the requirement of|
|°|:<br>;<br>Shriram Institute for<br>_ <br>Industrial Research (Aunitgranted<br>ofShriram Scientific and<br>Industrial Research<br>Foundation), 19-||esting from the laboratories mentioned at (i)<br> abovemaybewaivedoff, inviewofapproval<br>granted<br>by<br>these<br>countries’<br>regulatory<br>agencies<br>for<br>plants/section<br>engaged<br>in<br>manufacturingandexportofCough Syrup.|
||University Road, New||(iii) Further, ifCough Syrup is manufactured|
||Delhi-110007||in a plant/section approved by the regulatory|
||||agencies forabove mentioned countries at (ii)|
||||for any product, such Cough Syrup shall be|
||||permitted<br>to be exported<br>to any country|
||||withouttestingasmandatedat(i)above.|

Effect of this Notification: The mandatory testing of the export sample of ‘Cough Syrup’ under HSN 3004 is exempted in certain situations as mentioned above in accordance with the required GMP benchmarks/standards.

(Santosh Kumar Sarangi) Director General of Foreign Trade Ex-Officio Additional Secretary, Government of India E-mail: dgft@nic.in

(Issued from F. No. 01/91/180/21/AM20/EC/Part-VII/e- 21207)